A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to SARS-CoV-2
Related studies linked through entity extraction aliases.
Molnupiravir and COVID-19 Mortality Reduction in the Omicron Era
- Status
- COMPLETED
- Phase
- N/A
Study SARS-CoV-2-CZ-PREVAL-II - Arm of the Olomouc Region
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age
- Status
- COMPLETED
- Phase
- PHASE2
Secondary Databased Post-marketing Surveillance Study of BNT162b2
- Status
- COMPLETED
- Phase
- N/A
Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay
- Status
- COMPLETED
- Phase
- N/A
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immunocompromised Patients
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- Status
- RECRUITING
- Phase
- PHASE4
A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)
- Status
- COMPLETED
- Phase
- PHASE2
SARS-CoV-2 Safety Study for the Treatment of COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE2
Viral Infection of HSPC Impacts Hematopoiesis
- Status
- RECRUITING
- Phase
- N/A
A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults
- Status
- COMPLETED
- Phase
- PHASE3
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Virus and Bronchial Epithelium in Children and the Elderly
- Status
- RECRUITING
- Phase
- NA
Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data
- Status
- COMPLETED
- Phase
- N/A
Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years
- Status
- COMPLETED
- Phase
- N/A
Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran
- Status
- COMPLETED
- Phase
- N/A